Dynamics of the HIV infection under antiretroviral therapy: A cellular automata approach

Physica A: Statistical Mechanics and its Applications

Volumn 392, Issue 19, 2013, Pages 4701-4716

  González, Ramón E R ^a,b   Coutinho, Sérgio ^a   Zorzenon Dos Santos, Rita Maria ^a   De Figueirêdo, Pedro Hugo ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

Author keywords

Cellular automata; Drug therapies; HIV infection; Pattern formation; Population dynamics

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELLULAR AUTOMATA; DISEASES; DYNAMICS; POPULATION DYNAMICS; POPULATION STATISTICS; ROBOTS; T-CELLS; VIRUSES;

CELL POPULATIONS; CELLULAR AUTOMATA MODELING; COMBINED THERAPY; CONTROL PARAMETERS; DIFFERENT TIME SCALE; HIV INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; PATTERN FORMATION;

DRUG THERAPY;

EID: 84880333231     PISSN: 03784371     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physa.2013.05.056     Document Type: Article

References (74)

1. World Health Organization Global HIV/AIDS response, Technical Report 2011 World Health Organization
2. Didier Trono, Carine Van Lint, Christine Rouzioux, Eric Verdin, Francoise Barré-Sinoussi, Tae-Wook Chun, and Nicolas Chomont HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals Science 329 5988 2010 174 180
3. Valentin Le Douce, Georges Herbein, Olivier Rohr, and Christian Schwartz Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage Retrovirology 7 2010 32
4. Douglas D. Richman, David M. Margolis, Martin Delaney, Warner C. Greene, Daria Hazuda, and Roger J. Pomerantz The challenge of finding a cure for HIV infection Science 323 5919 2009 1304 1307
5. +T cells Mathematical Biosciences 114 1 1993 81 125
6. Alan S. Perelson, Avidan U. Neumann, Martin Markowitz, John M. Leonard, and David D. Ho HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 271 5255 1996 1582 1586
7. Denise Kirschner, and G.F. Weeb Understanding drug resistance for monotherapy treatment of HIV infection Bulletin of Mathematical Biology 59 4 1997 763 785
8. Xiping Wei, Sajal K. Ghosh, Maria E. Taylor, Victoria A. Johnson, Emilio A. Emini, Paul Deutsch, Jeffrey D. Lifsonparallel, Sebastian Bonhoeffer, Martin A. Nowak, Beatrice H. Hahn, Michael S. Saag, and George M. Shaw Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117 122
9. Martin A. Nowak, and Robert M. May Virus Dynamics - Mathematical Principles of Immunology and Virology 2000 Oxford University Press
10. Alan S. Perelson, and Patrick W. Nelson Mathematical analysis of HIV-1 dynamics in vivo SIAM Review 41 1 1999 3 44
11. Alberto Landi, Alberto Mazzoldi, Chiara Andreoni, Matteo Bianchi, Andrea Cavallini, Marco Laurino, Leonardo Ricotti, Rodolfo Iuliano, Barbara Matteoli, and Luca Ceccherini-Nelli Modelling and control of HIV dynamics Computer Methods and Programs in Biomedicine 89 2007
12. Libin Rong, and Alan S. Perelson Modeling HIV persistence, the latent reservoir, and viral blips Journal of Theoretical Biology 260 2 2009 308 331
13. Freda Wasserstein-Robbins A mathematical model of HIV infection: simulating T4, T8, macrophages, antibody, and virus via specific anti-HIV response in the presence of adaptation and tropism Bulletin of Mathematical Biology 2010 1208 1253
14. R.J. Smith, and L.M. Wahl Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects Bulletin of Mathematical Biology 66 5 2004 1259 1283
15. O. Krakovska, and L.M. Wahl Optimal drug treatment regimens for HIV depend on adherence Journal of Theoretical Biology 246 3 2007 499 509
16. Jorge Ferreira, Esteban A. Hernandez-Vargas, and Richard H. Middleton Computer simulation of structured treatment interruption for HIV infection Computer Methods and Programs in Biomedicine 104 2 2011 50 61
17. Rita Maria Zorzenon dos Santos, and Sérgio Coutinho Dynamics of HIV infection: a cellular automata approach Physical Review Letters 87 16 2001 168102
18. Ch.F. Kougias, and J. Schulte Simulating the immune response to the HIV-1 virus with cellular automata Journal of Statistical Physics 60 1990 263 273 10.1007/BF01013677
19. R.B. Pandey, and D. Stauffer Metastability with probabilistic cellular automata in an HIV infection Journal of Statistical Physics 61 1-2 1990 235 240
20. R.B. Pandey Cellular automata approach to interacting cellular network models for the dynamics of cell population in an early HIV infection Physica A: Statistical Mechanics and its Applications 179 3 1991 442 470
21. + T cell demographics and dynamics in lymphatic tissues Annual Review of Immunology 17 1999 625 656
22. P.H. Figueirêdo, S. Coutinho, and R.M. Zorzenon dos Santos Robustness of a cellular automata model for the HIV infection Physica A: Statistical Mechanics and its Applications 387 26 2008 6545 6552
23. Guillermo Solovey, Fernando Peruani, Silvina Ponce Dawson, and Rita Maria Zorzenon dos Santos On cell resistance and immune response time lag in a model for the HIV infection Physica A: Statistical Mechanics and its Applications 343 2004 543 556
24. Matthew C. Strain, and Herbert Levine Comment on "dynamics of HIV infection: a cellular automata approach" Physical Review Letters 89 2002 219805
25. E. Burkhead, J. Hawkins, and D. Molinek A dynamical study of a cellular automata model of the spread of HIV in a lymph node Bulletin of Mathematical Biology 71 1 2009 25 74
26. Peter M.A. Sloot, Fan Chen, and Charles Boucher Cellular automata model of drug therapy for HIV infection ACRI'01: Proceedings of the 5th International Conference on Cellular Automata for Research and Industry 2002 Springer-Verlag London, UK 282 293
27. A. Benyoussef, N.E. HafdiAllah, A. ElKenz, H. Ez-Zahraouy, and M. Loulidi Dynamics of HIV infection on 2D cellular automata Physica A 322 2003 506 520
28. M.A. Peer, N.A. Shan, and K.A. Khan Cellular automata and its advances to drug therapy for HIV infection Indian Journal of Experimental Biology 42 2 2004 131 137
29. Veronica Shi, Abdessamad Tridane, and Yang Kuang A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment Journal of Theoretical Biology 253 1 2008 24 35
30. +T cell dynamics with a proposed alternative leukapheresis treatment for HIV/AIDS Computers in Biology and Medicine 41 7 2011 546 558
31. Lucia Palmisano, and Stefano Vella A brief history of antiretroviral therapy of HIV infection: success and challenges Annali dell'Istituto Superiore di Sanità 47 1 2011 44 48
32. Kosuke Miyauchi, Yuri Kim, Olga Latinovic, Vladimir Morozov, and Gregory B. Melikyan HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes Cell 137 3 2009 433 444
33. Warner C. Greene, and B. Matija Peterlin Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy Nature Medicine 8 7 2001 673 680 07
34. B.Matija Peterlin, and Didier Trono Hide, shield and strike back: how HIV-infected cells avoid immune eradication Nature Reviews Immunology 3 2 2003 97 107
35. G. Pantaleo, C. Graziozi, and A.S. Fauci The immunopathogenesis of immunodeficiency virus infection New England Journal of Medicine 238 1993 327
36. J.M. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science (New York, NY) 267 5197 1995 483 489
37. Eric S. Daar, Tarsem Moudgil, Richard D. Meyer, and David D. Ho Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection New England Journal of Medicine 324 14 1991 961 964 01
38. Alan S. Perelson Modelling viral and immune system dynamics Nature Reviews Immunology 2 1 2002 28 36
39. Anthony S. Fauci HIV and AIDS: 20 years of science Nature Medicine 9 7 2003 839 843
40. David D. Ho, Avidan U. Neumann, Alan S. Perelson, Wen Chen, John M. Leonard, and Martin Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123 126
41. Alon Herschhorn, and Amnon Hizi Retroviral reverse transcriptases Cellular and Molecular Life Sciences 67 16 2010 2717 2747
42. Yazan El Safadi, Valérie Vivet-Boudou, and Roland Marquet HIV-1 reverse transcriptase inhibitors Applied Microbiology and Biotechnology 75 4 2007 723 737
43. Carlo Federico Perno The discovery and development of HIV therapy: the new challenges Annali dell'Istituto Superiore di Sanitá 4 1 2011 41 43
44. Michael F. Schneider, Stephen J. Gange, Carolyn M. Williams, Kathryn Anastos, Ruth M. Greenblatt, Lawrence Kingsley, Roger Detels, and Alvaro Muñoz Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004 AIDS 19 17 2005 2009 2018
45. Christophe Marchand, Kasthuraiah Maddali, Mathieu Métifiot, and Yves Pommier HIV-1 IN inhibitors: 2010 update and perspectives Current Topics in Medicinal Chemistry 9 11 2009 1016 1037
46. Annemarie M.J. Wensing, Noortje M. van Maarseveen, and Monique Nijhuis Fifteen years of HIV protease inhibitors: raising the barrier to resistance Antiviral Research 85 1 2010 59 74
47. David D. Ho Dynamics of HIV-1 replication in vivo Journal of Clinical Investigation 99 1997 2565 2567
48. M.A. Nowak, Roy M. Anderson, Maarten V. Boerlijts, S. Bonhoeffer, and Robert M. May HIV-1 evolution and disease progression Science 274 1996 1008 1011
49. Tae-wook Chun, Lucy Carruth, Diana Finzi, Xuefei Shen, Joseph A. DiGiuseppe, Harry Taylor, Monika Hermankova, Karen Chadwick, Joseph Margolik, Thomas C. Quinn, Yen-Hong Kuo, Ronald Brookmeyer, Martha A. Zeiger, Patricia Barditch-Crovo, and Robert F. Siliciano Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection Nature 387 1997 182 188
50. Tae-Wook Chun, and Anthony S. Fauci Latent reservoirs of HIV: obstacles to the eradication of virus Proceedings of the National Academy of Sciences of the United States of America 96 20 1999 10958 10961
51. +T cells Nature Medicine 9 6 2003 727 728
52. Tae-Wook Chun, David C. Nickle, J. Shawn Justement, Danielle Large, Alice Semerjian, Marcel E. Curlin, M. Angeline O'Shea, Claire W. Hallahan, Marybeth Daucher, Douglas J. Ward, Susan Moir, James I. Mullins, Colin Kovacs, and Anthony S. Fauci HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoirs Journal of Clinical Investigation 115 11 2005 3250 3255
53. Yangxin Huang, and Tao Lu Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study The Annals of Applied Statistics 2 4 2008 1384 1408
54. David R. Bangsberg, Edwin D. Charlebois, Robert M. Grant, Mark Holodniy, Steven G. Deeks, Sharon Perry, Kathleen Nugent Conroy, Richard Clark, David Guzman, Andrew Zolopa, and Andrew Moss High levels of adherence do not prevent accumulation of HIV drug resistance mutations AIDS 17 13 2003 1925 1932
55. Edward P. Acosta, Hulin Wu, Scott M. Hammer, Song Yu, Daniel R. Kuritzkes, Ann Walawander, Joseph J. Eron, Carl J. Fichtenbaum, Carla Pettinelli, Denise Neath, Elaine Ferguson, Alfred J. Saah, and John G. Gerber Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals Journal of Acquired Immune Deficiency Syndromes 37 3 2004 1358 1366
56. Vladimir Novitsky, Rui Wang, Hermann Bussmann, Shahin Lockman, Marianna Baum, Roger Shapiro, Ibou Thior, Carolyn Wester, C. William Wester, Anthony Ogwu, Aida Asmelash, Rosemary Musonda, Adriana Campa, Sikhulile Moyo, Erik van Widenfelt, Madisa Mine, Claire Moffat, Mompati Mmalane, Joseph Makhema, Richard Marlink, Peter Gilbert, George R. Seage, Victor DeGruttola, and M. Essex HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission PLoS One 5 4 2010 e10148
57. When To Start Consortium Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Lancet 373 9672 2009 1352 1363
58. N. Siegfried, O.A. Uthman, and G.W. Rutherford Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults Cochrane Database of Systematic Reviews 17 3 2010 CD008272
59. The Opportunistic, Infections Project, and Observational HIV CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE PLoS Medicine 9 3 2012 e1001194
60. +T cell homeostasis and function in advanced HIV disease Science 277 5322 1997 112 116
61. A. Ruffault, C. Michelet, C. Jacquelinet, O. Guist'au, N. Genetet, C. Bariou, R. Colimon, and F. Cartier The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 9 4 1995 243 248
62. +T cell repopulation of lymphoid tissues after treatment of HIV-1 infection PNAS 95 3 1998 1154 1159
63. Ferdinand W.N.M. Wit, Remko van Leeuvwen, Gerrit Jan Weverling, Suzanne Jurriaans, Klaas Nauta, Radjin Steingrover, Johan Schuijtemaker, Xander Eyssen, David Fortuin, Marjan Weeda, Frank de Wolf, Peter Reiss, Sven A. Danner, and Joep M.A. Lange Outcome and predictors of failure of higlhy active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons The Journal of Infectious Diseases 179 1999 790 798
64. Gilbert R. Kaufmann, Luc Perrin, Guiseppe Pantaleo, Milos Opravil, Hansjakob Furrer, Amalio Telenti, Bernard Hirschel, Bruno Ledergerber, Pietro Vernazza, Enos Bernasconi, Martin Rickenbach, Matthias Egger, and Manuel Battegay CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV cohort study Archives of Internal Medicine 163 18 2003 2187 2195
65. R.D. Hockett, J.M. Kilby, C.A. Derdeyn, M.S. Saag, M. Sillers, K. Squires, S. Chiz, M.a. Nowak, G.M. Shaw, and R.P. Bucy Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA The Journal of Experimental Medicine 189 10 1999 1545 1554
66. R.H. Enting, J.M. Prins, S. Jurriaans, K. Brinkman, P. Portegies, and J.M. Lange Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection Clinical Infectious Diseases 32 7 2001 1095 1099
67. Asa Mellgren, Andrea Antinori, Paola Cinque, Richard W. Price, Christian Eggers, Lars Hagberg, and Magnus Gisslén Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment Antiviral Therapy 10 6 2005 701 707
68. W. Cavert Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection Science 276 5314 1997 960 964
69. H. Wu, and A.A. Ding Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials Biometrics 55 2 1999 410 418
70. A.V.M. Herz, S. Bonhoeffer, R.M. Anderson, R.M. May, and M.A. Nowak Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay Proceedings of the National Academy of Sciences of the United States of America 93 14 1996 7247 7251
71. Alan S. Perelson, Paulina Essunger, Yunzhen Cao, Mika Vesanen, Arlene Hurley, Kalle Saksela, Martin Markowitz, and David Ho Decay characteristics of HIV-1-infected compartments during combination therapy Nature 387 6629 1997 188 191
72. Anthony P. Fitzgerald, Victor G. DeGruttola, and Florin Vaida Modelling HIV viral rebound using non-linear mixed effects models Statistics in Medicine 21 14 2002 2093 2108
73. Viktor Müller, Javier Flavio Vigueras-Gómez, and Sebastian Bonhoeffer Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection Journal of Virology 76 17 2002 8963 8965
74. Viviana Simon, and David D. Ho HIV-1 dynamics in vivo: implications for therapy Nature Reviews Microbiology 1 2003 181 190